Cargando…
Inhibition of NF-kappaB activity in mammary epithelium increases tumor latency and decreases tumor burden
The transcription factor nuclear factor kappa B (NF-κB) is activated in human breast cancer tissues and cell lines. However, it is unclear whether NF-κB activation is a consequence of tumor formation or a contributor to tumor development. We developed a doxycycline-inducible mouse model, termed DNMP...
Autores principales: | Connelly, Linda, Barham, Whitney, Onishko, Halina M., Sherrill, Taylor, Chodosh, Lewis A., Blackwell, Timothy S., Yull, Fiona E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3063854/ https://www.ncbi.nlm.nih.gov/pubmed/21076466 http://dx.doi.org/10.1038/onc.2010.521 |
Ejemplares similares
-
NF-kappaB activation within macrophages leads to an anti-tumor phenotype in a mammary tumor lung metastasis model
por: Connelly, Linda, et al.
Publicado: (2011) -
Aberrant activation of NF-κB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ
por: Barham, Whitney, et al.
Publicado: (2015) -
Increased canonical NF-kappaB signaling specifically in macrophages is sufficient to limit tumor progression in syngeneic murine models of ovarian cancer
por: Hoover, Alyssa A., et al.
Publicado: (2020) -
NF-kappaB in Lung Tumorigenesis
por: Cai, Zhenjian, et al.
Publicado: (2011) -
Expression of p52, a non-canonical NF-kappaB transcription factor, is associated with poor ovarian cancer prognosis
por: Hufnagel, Demetra H., et al.
Publicado: (2020)